People with suppressed immune systems may not have gotten adequate protection from initial doses of COVID vaccine and may need a booster, FDA says.
Author: Karen Weintraub, USA TODAY
Delta variant substantially more contagious than other variants, CDC presentation warns
Evidence is mounting about the dangers of the delta variant and how mask-wearing is essential to bring it under control, according to a CDC memo.
COVID booster shot ‘would be helpful’ for immunocompromised people, advisory committee recommends
People who are severely immune-compromised should consider getting a third dose of a COVID-19 vaccine, a federal advisory committee said on Thursday.
The fourth wave of COVID-19 cases is here. Will we escape the UK’s fate? It’s too soon to know.
COVID-19 may not be as deadly in this new wave, because older people are largely vaccinated and younger people are less likely to die.
Decades-long quest to beat Fragile X fueled by persistence, science and relentless optimism
After decades of frustration, failed trials and dashed dreams, signs of progress finally emerge in treatments for the rare genetic condition Fragile X.
The same mRNA technology used in COVID-19 vaccines could help treat cancer
Fighting COVID-19 proved a boon to cancer research. Here’s how scientists are using the same mRNA technology to attack tumors.
Novavax vaccine over 90% effective in protecting against COVID-19 infection, study shows
Novavax, one of five COVID vaccine-makers to receive large federal grants, says its shots are more than 90% effective against infection.
It’s been 40 years since the first reported cases of AIDS. While treatments have come a long way, a vaccine remains elusive.
The parallels between AIDS/HIV and COVID-19 and the virus that causes it are stark. But the differences are striking, too.
CDC reports 13 additional cases of blood clots linked to J&J COVID-19 vaccine. All happened before 11-day pause in its use.
The newly revealed cases all occurred in people before the government’s 11-day pause in J&J’s single-dose vaccine last month.
Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccine
Like other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.